(Q54033702)

23 May 2018

title

Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. (English)

1 reference

23 May 2018

1 reference

G M Brodeur

1 reference

23 May 2018

author name string

M A Grotzer

1 reference

23 May 2018

A Eggert

1 reference

23 May 2018

T J Zuzak

1 reference

23 May 2018

A J Janss

1 reference

23 May 2018

S Marwaha

1 reference

23 May 2018

B R Wiewrodt

1 reference

23 May 2018

N Ikegaki

1 reference

23 May 2018

P C Phillips

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 September 2000

1 reference

23 May 2018

published in

Oncogene

1 reference

23 May 2018

volume

1 reference

23 May 2018

issue

1 reference

23 May 2018

page(s)

4604-4610

1 reference

23 May 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Structure and chromosome localization of the human CASP8 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

A novel receptor for Apo2L/TRAIL contains a truncated death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

APO2L/TRAIL expression in human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

APO2 ligand: a novel lethal weapon against malignant glioma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Apoptosis signaling by death receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

The pathophysiology of tumor necrosis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

CD95 ligand-induced apoptosis of human medulloblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

Relative quantitative RT-PCR protocol for TrkB expression in neuroblastoma using GAPD as an internal control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

inferred from DOI database lookup

7 January 2021

based on heuristic

Brain tumors in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of fas death signals by FLIPs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203816

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1203816

1 reference

23 May 2018

1 reference

23 May 2018